Cargando…
Targeting the MYC Oncogene in Burkitt Lymphoma through HSP90 Inhibition
Overexpression of the MYC oncogene is a key feature of many human malignancies including Burkitt lymphoma. While MYC is widely regarded to be a promising therapeutic target, a clinically effective MYC inhibitor is still elusive. Here, we report an alternative strategy, targeting MYC indirectly throu...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266960/ https://www.ncbi.nlm.nih.gov/pubmed/30453475 http://dx.doi.org/10.3390/cancers10110448 |